Nouvelle déclaration d'incident
No de la demande: 2016-3101
Numéro de référence du titulaire d'homologation: 160007089
Nom du titulaire (nom légal complet, aucune abbréviation): Wellmark International
Adresse: 100 Stone Road West, Suite 111
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G5L3
Incident chez un animal domestique
Pays: UNITED STATES
État: WASHINGTON
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2724-815
Nom du produit: Kirkland Signature Flea And Tick Control For Medium Dogs 13-31 Lbs
Liquide
Oui
Unités: mL
Site: Animal / Usage sur un animal domestique
Inconnu
Propriétaire de l'animal
Dog / Chien
Dachshund Mix
1
Homme
3.0
Inconnu
Cutanée
Unknown / Inconnu
<=30 min / <=30 min
Système
Persisted until death
Inconnu
Inconnu
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On January 15, 2014 the dog developed alopecia and anorexia. On April 15, 2014 the dog died and the dog's regular veterinarian said the dog had acute hepatic failure. At the time, blood work and a necropsy could not be performed due to finances. On January 15, 2016 the owner was going to use the product on the dogs he has now and the owner's regular veterinarian told him not to, as the product caused the liver failure in the previous dogs. So the owner contacted the Animal Product Safety Service (APSS) to report the deaths. The APSS veterinarian stated etofenprox is in the pyrethroid family, and is safe to use on cats and dogs and it does not result in tremors or seizure activity that can be seen from other pyrethroids, since it is structurally different. The APSS veterinarian also stated dermal exposures may cause mild dermal irritation and hyperesthesia within the first 24-48 hours, and possibly secondary alopecia from pruritus. The APSS veterinarian additionally stated oral exposures often result in hypersalivation, nausea, and possibly hiding because of the taste and some animals will hypersalivate just from the odor of the product. The APSS veterinarian further stated s-methoprene is an insect growth regulator (IGR) and primary concerns from topical administration are for mild dermal irritation and redness, usually from the carriers, and if ingested there could be hypersalivation and nausea. The APSS veterinarian finally stated piperonyl butoxide is a synergist to enhance the efficacy of the ingredients.
Mort
The APSS veterinarian stated that the substance was not considered to be related to causing the clinical situation. The APSS technician provided the manufacturer's contact information as the owner stated he wanted the product taken off the market.
Propriétaire de l'animal
Dog / Chien
Dachshund Mix
1
Femme
2.0
Inconnu
Cutanée
Unknown / Inconnu
<=30 min / <=30 min
Système
Persisted until death
Inconnu
Inconnu
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On January 15, 2014 the dog developed alopecia and anorexia. On April 15, 2014 the dog died and the dog's regular veterinarian said the dog had acute hepatic failure. At the time, blood work and a necropsy could not be performed due to finances. On January 15, 2016 the owner was going to use the product on the dogs he has now and the owner's regular veterinarian told him not to, as the product caused the liver failure in the previous dogs. So the owner contacted the Animal Product Safety Service (APSS) to report the deaths. The APSS veterinarian stated etofenprox is in the pyrethroid family, and is safe to use on cats and dogs and it does not result in tremors or seizure activity that can be seen from other pyrethroids, since it is structurally different. The APSS veterinarian also stated dermal exposures may cause mild dermal irritation and hyperesthesia within the first 24-48 hours, and possibly secondary alopecia from pruritus. The APSS veterinarian additionally stated oral exposures often result in hypersalivation, nausea, and possibly hiding because of the taste and some animals will hypersalivate just from the odor of the product. The APSS veterinarian further stated s-methoprene is an insect growth regulator (IGR) and primary concerns from topical administration are for mild dermal irritation and redness, usually from the carriers, and if ingested there could be hypersalivation and nausea. The APSS veterinarian finally stated piperonyl butoxide is a synergist to enhance the efficacy of the ingredients.
Mort
The APSS veterinarian stated that the substance was not considered to be related to causing the clinical situation. The APSS technician provided the manufacturer's contact information as the owner stated he wanted the product taken off the market.